FGL2 and prostate carcinoma: For instance, we have shown that knockdown of FGL2 in a prostate carcinoma cell line reduced subcutaneous xenograft tumor growth and angiogenesis in a SCID mice model via the involvement of FGL2 in the MAPK signaling pathway [20].